Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,338 | -136,125 | -109,054 | -82,353 | -42,811 |
| Depreciation Amortization | 880 | 4,452 | 3,939 | 2,955 | 1,758 |
| Accounts payable and accrued liabilities | -1,039 | -5,412 | -4,979 | -1,237 | -957 |
| Other Working Capital | 8,228 | -8,491 | -7,551 | -5,511 | -11,495 |
| Other Operating Activity | 3,823 | 27,366 | 23,456 | 15,352 | 8,794 |
| Operating Cash Flow | $-22,446 | $-118,210 | $-94,189 | $-70,794 | $-44,711 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,243 | 30,473 | 33,357 | 36,371 | 19,536 |
| PPE Investments | -26 | -2,274 | -1,800 | -1,556 | -725 |
| Purchase Sale Intangibles | N/A | -3,000 | -3,000 | -1,500 | -1,500 |
| Other Investing Activity | 0 | -3,000 | -3,000 | -1,500 | -1,500 |
| Investing Cash Flow | $21,217 | $25,199 | $28,557 | $33,315 | $17,311 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 433 | 371 | 292 | 49 |
| Other Financing Activity | 0 | -1,786 | -1,136 | -649 | 0 |
| Financing Cash Flow | $N/A | $-1,353 | $-765 | $-357 | $49 |
| Beginning Cash Position | 34,601 | 128,965 | 128,965 | 128,965 | 128,965 |
| End Cash Position | 33,372 | 34,601 | 62,568 | 91,129 | 101,614 |
| Net Cash Flow | $-1,229 | $-94,364 | $-66,397 | $-37,836 | $-27,351 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,446 | -118,210 | -94,189 | -70,794 | -44,711 |
| Capital Expenditure | -26 | -2,274 | -1,800 | -1,556 | -725 |
| Free Cash Flow | -22,472 | -120,484 | -95,989 | -72,350 | -45,436 |